Christopher Simon

Insider Reports History

Location
Boston, MA
Signature
Gregory S. Harvey, Attorney-in-Fact
Transaction view
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Christopher Simon:

Form 4 holding President & CEO, Director

HAEMONETICS CORP

Security class
Non-qualified Stock Option (Right to Buy)
Shares / value
46,342
Estimated value
Report date
16 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President & CEO, Director

HAEMONETICS CORP

Security class
Non-qualified Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
06 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Christopher Simon

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .